Six-year monitoring of the donor-specific immune response to cryopreserved aortic allograft valves: Implications with valve dysfunction  Giulio Pompilio,

Slides:



Advertisements
Similar presentations
Aortic Valve Replacement With Patch Enlargement of the Aortic Annulus
Advertisements

Ten-year trends in heart valve replacement operations
Wenrui Ma, MD, Wei Zhang, MD, Wei Shi, MD, Ye Kong, MD, Xinyu Ma, MS 
Reply The Annals of Thoracic Surgery
Unusual Gastrointestinal Bleeding After Sutureless Aortic Valve Replacement: A Word of Caution  Jules Iquille, MD, Joseph Nader, MD, Eric Colpart, MD,
Outcomes of Reintervention on the Autograft After Ross Procedure
Sreekumar Subramanian, MD, Sergey Leontyev, MD, Michael A
Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M
Immunology and failure of valved allografts in children
Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability?  Tirone E. David, MD, Susan Armstrong, MS,
Is a bicuspid aortic valve a risk factor for adverse outcome after an autograft procedure?  Ad J.J.C Bogers, MD, PhD, Arie-Pieter Kappetein, MD, PhD,
Effectiveness of Hyperbaric Oxygen Therapy for Hearing Loss After Cardiac Surgery  Giuseppe Bruschi, MD, Giuseppe Tarelli, MD, Paola Colombo, MD, PhD,
CTSNet: a unique educational vehicle
Factors Influencing HLA Sensitization in Implantable LVAD Recipients
Aortic valve replacement with the biocor PSB stentless xenograft
Ten-year trends in heart valve replacement operations
Roh Yanagida, MD, PhD, Lawrence S. C. Czer, MD, Nancy L
Long-Term Outcomes of the Mosaic Bioprosthesis
Aortic Valve Replacement With 17-mm St
Which Patients Benefit From Stentless Aortic Valve Replacement?
The “Double-Valve” Sign in Acute Type A Aortic Dissection
Andreas Zierer, MD, Rochus K. Voeller, MD, Karen E
Outcomes of Mechanical Valves in the Pulmonic Position in Patients With Congenital Heart Disease Over a 20-Year Period  Hong Ju Shin, MD, Young-Hwue Kim,
Redundant Anterior Aortic Valve
Use of Amiodarone After Major Lung Resection
Are older patients with mechanical heart valves at increased risk?
Zain Khalpey, MD, PhD, Wernard Borstlap, Patrick O. Myers, MD, Jan D
Extracardiac myxoma: An unusual right ventricular epicardial location
Low-Dose Prophylactic Intravenous Immunoglobulin Does Not Prevent HLA Sensitization in Left Ventricular Assist Device Recipients  Stavros G. Drakos, MD,
Determinants of Left Ventricular Dysfunction After Repair of Chronic Asymptomatic Mitral Regurgitation  Vincent Chan, MD, MPH, Marc Ruel, MD, MPH, Elsayed.
Long-Term Outcomes of Open Arch Repair After a Prior Aortic Operation: Our Experience in 154 Patients  Roberto Di Bartolomeo, MD, Paolo Berretta, MD,
Transcatheter Aortic Valve Replacement: How I Teach It
Percutaneous Transcatheter Closure of the Aortic Valve
Redo Aortic Valve Replacement in Children
Robert W. Emery, MD, Christopher C. Krogh, Kit V. Arom, MD, PhD, Ann M
Editorial Board, January 2010
Long-Term Survival and Freedom From Reoperation After Placement of a Pulmonary Xenograft Valved Conduit  George M. Alfieris, MD, Michael F. Swartz, PhD,
Aortic Root Replacement for Children With Loeys-Dietz Syndrome
Midterm Outcome of Valve-Sparing Aortic Root Replacement in Inherited Connective Tissue Disorders  Hiroshi Tanaka, MD, PhD, Hitoshi Ogino, MD, PhD, Hitoshi.
Bhawna Gupta, PhD, Ali Dodge-Khatami, MD, PhD, Charles D
Surgical Treatment of Aortic Prosthetic Valve Endocarditis: A 20-Year Single-Center Experience  Sossio Perrotta, MD, Anders Jeppsson, MD, PhD, Victoria.
Pretransplant Panel Reactive Antibodies in Human Lung Transplantation: An Analysis of Over 10,000 Patients  Ashish S. Shah, MD, Lois Nwakanma, MD, Christopher.
Deterioration of a Tricuspid Bioprosthesis Due to Adhesion of the Native Valve  Herbert Gutermann, MD, Willem Flameng, MD, PhD, Paul Herijgers, MD, PhD 
Hans-Joachim Schäfers, MD, PhD, Diana Aicher, MD, Frank Langer, MD 
Transapical Aortic Valve Implantation in High-Risk Patients With Severe Aortic Valve Stenosis  Augusto D'Onofrio, MD, Melissa Fusari, MD, Nicola Abbiate,
Surgical Treatment of Aortic Valve Regurgitation Secondary to Ascending Aorta Aneurysm: Is Adjunctive Subcommissural Annuloplasty Necessary?  Charles.
The Annals of Thoracic Surgery
Paul Urbanski, MD, PhD  The Annals of Thoracic Surgery 
David P. Mason, MD, Chase R. Brown, BS, Sudish C
Arnt E Fiane, MD, Odd R Geiran, MD, PhD, Jan L Svennevig, MD, PhD 
Twenty-Five Year Outcomes of Tricuspid Valve Replacement Comparing Mechanical and Biologic Prostheses  Andrea Garatti, MD, Giovanni Nano, MD, Giuseppe.
Scott B. Johnson, MD, Anna M. Allred, BS, Adam M. Cline, MD, Luis F
Sharven Taghavi, MD, MPH, Senthil N
Total Arterial Off-Pump Coronary Surgery: Time to Change Our Habits?
Postoperative Coronary Artery Spasm Complicating Aortic Valve Replacement: Implications for Identification and Treatment  Claudio Pragliola, MD, Luca.
Antibodies to Self-Antigens Predispose to Primary Lung Allograft Dysfunction and Chronic Rejection  Ankit Bharat, MD, Deepti Saini, PhD, Nancy Steward,
Steve K. Singh, MD, Gilbert H. L. Tang, MD, Manjula D
Postoperative Cognitive Dysfunction and Aortic Atheroma
Experience With Bovine Pericardium for the Reconstruction of the Aortic Arch in Patients Undergoing a Norwood Procedure  Victor O. Morell, MD, Peter A.
Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS 
Cavernous Hemangioma of the Posterior Mediastinum
Aortic Valve Replacement Surgery: Comparison of Outcomes in Matched Sternotomy and PORT ACCESS Groups  William T. Brinkman, MD, William Hoffman, MD, Todd.
Small “Functional” Size after Mechanical Aortic Valve Replacement: No Risk in Young to Middle-Age Patients  Alfonso Penta de Peppo, MD, Jacob Zeitani,
Is Surgery Always Mandatory for Type A Aortic Dissection?
Aortic root replacement versus aortic valve replacement: a case-match study  Paul P Urbanski, MD, Matthias Wagner, MD, Michael Zacher, MD, Robert W Hacker,
Selecting patients with mitral regurgitation and left ventricular dysfunction for isolated mitral valve surgery  Constance K. Haan, MD, Cristina I. Cabral,
Risk of Valve-Related Events After Aortic Valve Repair
Heart Transplant Program Volume Is Not a Measure of Quality
Aortic Valve Function After Bicuspidization of the Unicuspid Aortic Valve  Diana Aicher, MD, Moritz Bewarder, Michael Kindermann, MD, Hashim Abdul-Khalique,
Michael O. Kayatta, MD, Bradley G
Presentation transcript:

Six-year monitoring of the donor-specific immune response to cryopreserved aortic allograft valves: Implications with valve dysfunction  Giulio Pompilio, MD, PhD, GianLuca Polvani, MD, Giuseppe Piccolo, MD, Anna Guarino, BS, Angela Nocco, BS, Annalisa Innocente, Massimo Porqueddu, MD, PhD, Luca Dainese, MD, Fabrizio Veglia, PhD, Andrea Sala, MD, Paolo Biglioli, MD  The Annals of Thoracic Surgery  Volume 78, Issue 2, Pages 557-563 (August 2004) DOI: 10.1016/j.athoracsur.2004.02.037

Fig 1 Percent of recipients with a positive panel-reactive antibody (PRA) during the follow-up period. (Pts = patients.) The Annals of Thoracic Surgery 2004 78, 557-563DOI: (10.1016/j.athoracsur.2004.02.037)

Fig 2 Kinetics of HLA antibody production, measured as panel-reactive antibody (PRA) activity, after cryopreserved allograft valve replacement. (HLA = human leukocyte antigen; Pts = patients.) The Annals of Thoracic Surgery 2004 78, 557-563DOI: (10.1016/j.athoracsur.2004.02.037)

Fig 3 Freedom from structural deterioration (%) for patients with and without a peak panel-reactive antibody (PRA) more than 80%. PeakPRA > 80% (squares); peakPRA < 80% (triangles). (Pts = patients.) The Annals of Thoracic Surgery 2004 78, 557-563DOI: (10.1016/j.athoracsur.2004.02.037)

Fig 4 Freedom from structural deterioration (%) for patients with and without a 6-year permanent panel-reactive antibody (PRA) more than 70%. PermanentPRA < 70% (triangles); permanentPRA > 70% (squares). (Pts = patients.) The Annals of Thoracic Surgery 2004 78, 557-563DOI: (10.1016/j.athoracsur.2004.02.037)